Zacks Investment Research on MSN
Here's why Henry Schein (HSIC) is a strong value stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
Eine aktuelle Studie zeigt, dass durchschnittlich über 550 Bakterienarten im Kühlschrank lauern. Eine Expertin erklärt, warum ...
Zu seinem 48. Geburtstag lud Manfred Schein liebgewonnene Stammgäste und die Musiker/Musikanten seines Musikantenstammtisch, ...
BitMine-Chairman Tom Lee nennt drei Gründe, warum US-Aktien jetzt besser aufgestellt sind als zum Jahreshoch im Januar.
Ein 18-Jähriger wollte in Wels-Land vor der Polizei flüchten, hatte keinen Führerschein und stand offenbar unter Drogen.
Was bringt die Albrecht-Dürer-Forschung an neuen Erkenntnissen? Ein opulenter, knapp acht Kilo schwerer Bildband des ...
Over the past six months, Henry Schein has been a great trade, beating the S&P 500 by 17.3%. Its stock price has climbed to ...
In a report released today, Glen Santangelo from Barclays maintained a Buy rating on Viatris, with a price target of $17.00. Santangelo covers the Healthcare sector, focusing on stocks such as Teva ...
Henry Schein will announce its first-quarter earnings shortly, and analysts are expecting a single-digit increase in earnings ...
Laut Polizei habe der Mann bei seinem Besuch 7.000 Euro allein für die Vorbesichtigung gefordert – doch damit nicht genug.
Shares of Henry Schein Inc. HSIC rose 2.27% to $75.53 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 2.51% to 6,782.81 ...
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, today announced its plan to reduce the size of its Board of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results